SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sanofi – ‘6-K’ for 9/17/07

On:  Tuesday, 9/18/07, at 6:07am ET   ·   For:  9/17/07   ·   Accession #:  1193125-7-202537   ·   File #:  1-31368

Previous ‘6-K’:  ‘6-K’ on / for 9/11/07   ·   Next:  ‘6-K’ on / for 10/22/07   ·   Latest:  ‘6-K’ on 4/25/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/18/07  Sanofi                            6-K         9/17/07    2:215K                                   RR Donnelley/FA

Report of a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of a Foreign Private Issuer                  HTML     13K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     80K 


6-K   —   Report of a Foreign Private Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 6-K  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 


For the month of September 2007

Commission File Number: 001-31368

SANOFI-AVENTIS

(Translation of registrant’s name into English)

174, avenue de France, 75013 Paris, FRANCE

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x                Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):             

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                                 No x

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-            


In September 2007, sanofi-aventis issued the press release attached hereto as Exhibit 99.1, which is incorporated herein by reference.

Exhibit List

 

Exhibit No.    Description
Exhibit 99.1    Press release dated September 17, 2007: A promising R&D portfolio, well positioned to deliver future growth.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Dated: September 17, 2007   SANOFI-AVENTIS        
  By  

/S/  Patricia Kodyra

    Name:   Patricia Kodyra
    Title:     Associate Vice President
                  Financial and Securities Law

 

3


Exhibit Index

 

Exhibit No.    Description
Exhibit 99.1    Press release dated September 17, 2007: A promising R&D portfolio, well positioned to deliver future growth.

 

4


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘6-K’ Filing    Date    Other Filings
Filed on:9/18/07None on these Dates
For Period End:9/17/07
 List all Filings 
Top
Filing Submission 0001193125-07-202537   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 8:51:55.1am ET